Health

Paxlovid still offers high-risk COVID-19 patients protection against hospital admissions, study says


A new Canadian study has found the antiviral drug Paxlovid continued to protect higher-risk individuals against COVID-related hospital admissions and death even after the Omicron variant was in circulation. Much of the previous research into the effectiveness of nirmatrelvir–ritonavir, the two …

Read more

Show More

Related Articles

Back to top button